Figure 5From: Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin Model for the development of various resistance phenotypes in ovarian cancer. Following selection for drug resistance with the indicated drugs, a number of molecular pathways are altered. The molecular pathways identified as altered in the different conditions may be functionally related to the development of drug resistance.Back to article page